The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms

Annals of surgical oncology, 2020 - Springer
Abstract The Chicago Consensus Working Group provides multidisciplinary
recommendations for the management of appendiceal neoplasms specifically related to the …

Principles of surgical management of peritoneal mesothelioma

JA Steadman, TE Grotz - Journal of the National Comprehensive Cancer …, 2023 - jnccn.org
Malignant peritoneal mesothelioma (MPeM) is a rare malignancy and represents 5% to 30%
of malignant mesothelioma cases. The primary curative therapy for MPeM is radical …

Efficacy, safety, and biomarker analysis of combined PD-L1 (atezolizumab) and VEGF (bevacizumab) blockade in advanced malignant peritoneal mesothelioma

K Raghav, S Liu, MJ Overman, AF Willett, M Knafl… - Cancer …, 2021 - aacrjournals.org
Malignant peritoneal mesothelioma (MPeM) is a rare but aggressive malignancy with limited
treatment options. VEGF inhibition enhances efficacy of immune-checkpoint inhibitors by …

The Chicago consensus on peritoneal surface malignancies: management of colorectal metastases

Annals of surgical oncology, 2020 - Springer
Abstract The Chicago Consensus Working Group provides multidisciplinary
recommendations for the management of colorectal cancer specifically as it relates to the …

Perfusion strategies for cytoreductive surgery with heated intraperitoneal chemotherapy for malignant peritoneal mesothelioma

C Drigotas, AW Loftus, JB Ammori… - Journal of Surgical …, 2024 - Wiley Online Library
Cytoreductive surgery (CRS) with heated intraoperative intraperitoneal chemotherapy
(HIPEC) has been shown to improve survival for patients with malignant peritoneal …

The Chicago consensus on peritoneal surface malignancies: management of gastric metastases

Annals of surgical oncology, 2020 - Springer
Abstract The Chicago Consensus Working Group provides multidisciplinary
recommendations for the management of gastric cancer specifically as it relates to the …

Contemporary trends in malignant peritoneal mesothelioma: incidence and survival in the United States

L Calthorpe, F Romero-Hernandez, P Miller… - Cancers, 2022 - mdpi.com
Simple Summary This contemporary epidemiological analysis revealed a stable overall
incidence of malignant peritoneal mesothelioma (MPM), but improved recognition of …

2022 PSOGI Consensus on HIPEC regimens for peritoneal malignancies: Diffuse malignant peritoneal mesothelioma

V Kepenekian, O Sgarbura, F Marchal… - Annals of Surgical …, 2023 - Springer
Background Diffuse malignant peritoneal mesothelioma (DMPM) is a rare and aggressive
primary peritoneal disease, with recommended treatment, in eligible patients, of a …

Non-resectable malignant peritoneal mesothelioma treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) plus systemic chemotherapy could lead to …

V Kepenekian, J Péron, B You, I Bonnefoy… - Annals of Surgical …, 2022 - Springer
Background Diffuse malignant peritoneal mesothelioma (DMPM) is an aggressive primary
peritoneal neoplasia. At diagnosis, few patients are eligible for a recommended …

The Chicago Consensus on peritoneal surface malignancies: management of ovarian neoplasms

Annals of surgical oncology, 2020 - Springer
Abstract The Chicago Consensus Working Group provides multidisciplinary
recommendations for the management of ovarian neoplasms specifically related to the …